What are postbiotics for dogs?

Postbiotics are the beneficial, inactivated compounds — such as short-chain fatty acids, enzymes, and bacterial cell-wall fragments — that probiotic organisms produce during fermentation. In dogs they support gut-barrier integrity, digestion, and immune signaling without introducing live bacteria.

How do postbiotics work?

Postbiotics deliver the end-products of bacterial fermentation directly to the gut, where they help strengthen the intestinal lining and modulate immune responses. Because the organisms are already inactivated, the effect does not depend on live bacteria surviving stomach acid.

Are postbiotics safe for all dog breeds?

Postbiotics are generally considered safe for dogs of all breeds and ages because they contain no live organisms. As with any supplement, introduce them gradually and check with your veterinarian if your dog has a serious underlying condition.

How long does it take for postbiotics to work in dogs?

Many owners notice digestive improvements within two to four weeks of consistent daily use. Since postbiotics do not need to colonize the gut, their effects can appear sooner than those of live probiotics.

How do I choose the best postbiotics for my dog?

Look for a named, research-backed strain (for example an inactivated Lactobacillus), a clear serving size, and evidence of third-party testing. Stability and guaranteed shelf life matter more than a high CFU count, because postbiotics are not measured in live cultures.

Postbiotic Stability: Why Shelf Life Matters More Than CFU Count

Clinical Reviews · 9 min read

Our Veterinary Editorial Board — July 29, 2026

The probiotic industry measures potency in colony-forming units — a metric that is, by its nature, unstable. CFU counts degrade from the moment of manufacture, affected by temperature, moisture, oxygen, and time. The number on the label is a snapshot of a dying population. Postbiotics, by contrast, are measured in milligrams of inactivated material — a metric that does not degrade because the organisms are already dead. This article examines the stability science behind both paradigms and argues that shelf-life consistency is a more meaningful quality metric than the CFU count that dominates product marketing.

The Probiotic Viability Problem: A Quantitative Analysis

Live probiotic organisms are in a constant state of decline from the moment they are manufactured. The rate of decline depends on multiple interacting factors:

Temperature Kinetics

Bacterial death in dried preparations follows first-order kinetics, with the rate constant governed by the Arrhenius equation. In practical terms: for every 10°C increase in storage temperature, the rate of viability loss approximately doubles. Consider a product manufactured at 10 billion CFU:

Stored at 4°C (refrigerated): Approximately 80-90% viability retained at 12 months. Loss rate: ~1-2% per month.
Stored at 25°C (room temperature): Approximately 50-70% viability retained at 12 months. Loss rate: ~3-5% per month.
Stored at 35°C (summer warehouse/shipping): Approximately 20-40% viability retained at 12 months. Loss rate: ~6-10% per month.

These are approximate ranges — actual rates depend on the organism, the matrix, and the packaging. But the pattern is universal: heat kills, and the supply chain is full of heat.

The Cold Chain Gap

Products that require refrigeration face a practical challenge: the cold chain is fragile. A product may leave the manufacturer at 4°C, but then:

Sits in a non-refrigerated warehouse for days or weeks
Ships in an unrefrigerated truck or container (interior temperatures can exceed 50°C in summer)
Sits on a loading dock
Sits in a retail stockroom
Sits in the owner’s car trunk on the way home

Each of these steps introduces thermal excursions that accelerate viability loss. The product that arrives at the owner’s door may have experienced cumulative heat exposure equivalent to months of room-temperature storage, even if the label says “keep refrigerated.”

Water Activity and Format

The physical format of the product dramatically affects stability:

Lyophilized (freeze-dried) powders: Water activity (a_w) typically 0.1-0.2. Most stable format. Organisms are in a glassy, metabolically inert state.
Capsules with desiccant: a_w 0.2-0.4. Reasonably stable if the seal is intact.
Soft chews: a_w 0.6-0.8. Least stable format. Residual moisture permits slow metabolic activity, Maillard reactions, and oxidative damage. The most popular consumer format is also the least stable.
Liquid suspensions: a_w ~1.0. Least stable of all. Organisms are metabolically active and depleting nutrients. Refrigeration is mandatory.

The market trend toward soft chews — driven by palatability and owner convenience — directly conflicts with stability requirements.

Postbiotic Stability: The Physics of Dead Things

Postbiotics escape the viability problem because they have no viability to preserve. The inactivation process — typically heat treatment (tyndallization at 60-80°C for defined periods) — renders the organisms irreversibly non-viable. What remains is a chemically defined material:

What Survives Inactivation

Cell wall structures: Peptidoglycan, lipoteichoic acid (gram-positive), lipopolysaccharide fragments (gram-negative), surface-layer proteins. These are high-molecular-weight polymers with thermal stability far exceeding that of living cells. Peptidoglycan is stable to >200°C.
Heat-stable metabolites: Short-chain fatty acids (acetate, propionate, butyrate), organic acids (lactic acid), and certain bacteriocins survive standard inactivation temperatures.
Extracellular polysaccharides: EPS components produced during fermentation are generally heat-stable.
Intracellular enzymes: Some enzymes (bile salt hydrolase, certain proteases) retain partial activity after heat inactivation, depending on temperature and duration.

What Is Lost

Metabolic activity: The ability to ferment substrates, produce new metabolites, or respond to environmental signals. The organism is dead; it will not produce anything new.
Replication capacity: The organism will not colonize, multiply, or establish. This is a feature, not a bug, for safety and dosing consistency.
Heat-labile proteins: Some surface adhesins and heat-sensitive enzymes are denatured during inactivation. The specific losses depend on the inactivation protocol.

Shelf-Life Implications

Because the bioactive components of postbiotics are chemically stable polymers and small molecules — not living cells — their shelf-life degradation profile is fundamentally different:

No temperature sensitivity in the biological range. Storing a postbiotic at 4°C versus 35°C does not change its peptidoglycan content. The Arrhenius degradation that kills probiotics is irrelevant to already-dead material.
No moisture sensitivity (within normal ranges). Cell wall polymers do not “die” from moisture exposure. They may absorb water, but their immunomodulatory and structural properties are preserved.
No oxygen sensitivity. Dead organisms do not undergo oxidative metabolic damage. The cell wall components are not redox-active in the biological sense.
Shelf life limited by chemical, not biological, degradation. The relevant degradation pathways are Maillard browning, lipid oxidation (if the preparation contains membrane lipids), and slow hydrolysis — all of which operate on timescales of years, not months.

Dosing Consistency: The Clinical Argument

The stability difference between probiotics and postbiotics is not merely a logistical convenience. It has direct clinical implications:

Verifiable Dosing

A postbiotic label claiming “500 mg of inactivated Lactobacillus plantarum per serving” is making a claim that can be verified by standard analytical chemistry. The mass of cell wall material does not change between manufacture and consumption. A certificate of analysis (CoA) generated at manufacture remains valid at expiration.

A probiotic label claiming “10 billion CFU per serving” is making a claim that is true only at a specific moment under specific conditions. By the time the product is consumed, the actual viable count may be anywhere from 10% to 100% of the labeled value, depending on storage history. The CoA is a historical document, not a current guarantee.

Reproducible Clinical Response

If the dose varies by 50-90% depending on storage conditions, the clinical response will also vary. An owner who sees benefit from a fresh, properly stored product may see no benefit from the same product after a summer shipping delay. This variability:

Undermines owner confidence (“it worked last time but not this time”)
Complicates veterinary assessment (“is the product failing, or is the dose inadequate?”)
Makes clinical research harder to replicate (different batches, different storage histories)

Postbiotics eliminate this variability. Every dose contains the same mass of bioactive material, regardless of when it was manufactured, how it was shipped, or where it was stored. This consistency is a prerequisite for evidence-based supplementation.

Compatibility with Real-World Use

Dogs do not live in pharmaceutical-grade environments. Supplements are stored in kitchens, garages, cars, and travel bags. They are shipped across climate zones. They sit in warehouses. The postbiotic stability profile is compatible with real-world use; the probiotic cold-chain requirement is not.

The Evidence: Stability Data

Direct head-to-head stability comparisons between probiotic and postbiotic formulations of the same strain are limited in the veterinary literature. However, the underlying science is well-established:

Probiotic degradation: Multiple studies document progressive CFU loss in commercial products. Weese & Martin (2011; PMID: 21392016) found that 13 of 15 veterinary probiotic products failed to meet label claims — a finding consistent with storage-related degradation in addition to manufacturing variability.
Postbiotic stability: The ISAPP 2021 consensus (Salminen et al.; PMID: 33903774) notes that inactivation “confers stability to the preparation” as one of the defining advantages of the postbiotic category. Human postbiotic products (e.g., tyndallized L. plantarum preparations) demonstrate stable composition over 24-36 month shelf lives at room temperature.
Thermal stability of cell wall components: Peptidoglycan and lipoteichoic acid are stable to temperatures far exceeding those encountered in any storage or shipping scenario. Their degradation requires conditions (strong acid, prolonged high heat >200°C) that do not occur in normal product lifecycle.

Practical Implications for Product Selection

For veterinary professionals and owners evaluating supplement stability:

When Probiotic Stability Can Be Managed

The product uses spore-forming organisms (Bacillus spp.) with inherent thermal resistance
The product is lyophilized and sealed with desiccant
The cold chain is verifiable (pharmacy-dispensed, local purchase)
The product guarantees CFU “at expiration” and the manufacturer has stability data to support this

When Postbiotic Stability Is Preferable

The product will be shipped (e-commerce, mail-order)
Storage conditions are uncontrolled (boarding facilities, travel, field work)
The patient requires precise, consistent dosing (therapeutic protocols, research)
The owner cannot reliably maintain refrigeration
The product format is a soft chew or liquid (inherently less stable for live organisms)

Conclusion

Shelf life is not a secondary consideration in supplement quality — it is the primary determinant of what the animal actually receives. A product labeled “50 billion CFU” that delivers 5 billion at point of use is a 5-billion-CFU product, regardless of what the label says. Postbiotics resolve this problem at its root: by delivering inactivated material measured in stable mass units, they guarantee that the dose at consumption matches the dose at manufacture. No refrigeration. No cold chain. No viability anxiety. For applications where consistent, verifiable dosing matters — and in evidence-based medicine, it always matters — postbiotic stability is not a convenience feature. It is a quality prerequisite.

References

Salminen S, Collado MC, Endo A, et al. ISAPP consensus statement on postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-667. PMID: 33903774.
Weese JS, Martin H. Assessment of commercial probiotic products for dogs and cats. Can Vet J. 2011;52(3):287-290. PMID: 21392016.
Hill C, Guarner F, Reid G, et al. ISAPP consensus statement on probiotics. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514. PMID: 24912386.
Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability. Crit Rev Food Sci Nutr. 2011;51(4):261-274. PMID: 21432699.
Santoso A, et al. Stability of tyndallized Lactobacillus plantarum preparations under various storage conditions. J Appl Microbiol. 2020.

Frequently Asked Questions

Why don’t postbiotics need refrigeration?

Postbiotics are deliberately inactivated — the organisms are already dead. Refrigeration preserves probiotics by slowing the metabolic processes that kill live organisms during storage. Since postbiotics have no viability to preserve, temperature has minimal effect on their bioactive content. Cell wall components (peptidoglycan, lipoteichoic acid) and metabolites (SCFAs, bacteriocins) are chemically stable at room temperature throughout a typical 24-36 month shelf life.

How long do probiotics actually remain viable?

It depends on the organism, formulation, and storage conditions. Lyophilized powders stored at 4°C may retain 80-90% viability at 12 months. The same product at 25°C may retain only 50-70%. Soft chews (higher water activity) degrade faster than powders. Products labeled “CFU at manufacture” may have lost 50-80% of viable organisms by the time they reach the consumer. This variability is the core practical argument for postbiotic alternatives.

Does heat-killing destroy the beneficial properties?

Not entirely. Heat inactivation (tyndallization, typically 60-80°C) kills the organism but preserves most cell wall structures (peptidoglycan, lipoteichoic acid, surface proteins) and many heat-stable metabolites. These preserved components are responsible for the immunomodulatory, anti-adhesive, and antimicrobial effects attributed to postbiotics. What is lost is metabolic activity — the ability to produce new compounds in situ. What is retained is the existing bioactive payload.

Is consistent dosing really that important for supplements?

Yes, for two reasons. First, if you cannot verify what dose the animal actually receives, you cannot correlate outcomes with exposure — making it impossible to determine whether a product works or optimize its use. Second, variable dosing means variable clinical response, which erodes owner confidence and veterinary trust. Postbiotics deliver a fixed mass of bioactive material per dose, every time, regardless of storage history. This consistency is a prerequisite for evidence-based supplementation.

Postbiotic Stability: Why Shelf Life Matters More Than CFU Count